Book Review. Should Pharmaceutical Prices be Regulated? The Strengths and Weaknesses of the British Pharmaceutical Price Regulation Scheme, IEA Health and Welfare Unit, London, 1997, 133 pages, £12.00, ISBN 0‐255 36430‐X, ISSN 1362‐9565 [Book Review]

Health Care Analysis 6 (2):168-169 (1998)
  Copy   BIBTEX


This article has no associated abstract. (fix it)



    Upload a copy of this work     Papers currently archived: 92,150

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Big pharma: a story of success in a market economy. [REVIEW]Joao Calinas-Correia - 2013 - Medicine, Health Care and Philosophy 16 (2):305-309.
Ethics, pricing and the pharmaceutical industry.Richard A. Spinello - 1992 - Journal of Business Ethics 11 (8):617 - 626.
Pharmaceutical medicine.D. M. Burley & Theodore Barker Binns (eds.) - 1985 - Baltimore, Md., U.S.A.: E. Arnold.
The Pharmaceutical Benefits Scheme (PBS): Is It Equitable?Tracey Phelan - 2000 - Chisholm Health Ethics Bulletin 5 (4):10.


Added to PP

15 (#949,647)

6 months
1 (#1,475,085)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references